About Krankenhaus Barmherzige Brüder Regensburg, Klinik für Onkologie und Hämatologie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Heidelberg Medical Center
2
Krankenhaus Nordwest
1
University of Jena
1
Universität des Saarlandes
1
Clinical Trials at Krankenhaus Barmherzige Brüder Regensburg, Klinik für Onkologie und Hämatologie
During the past decade, Krankenhaus Barmherzige Brüder Regensburg, Klinik für Onkologie und Hämatologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
OPTIMAL>60 / DR. CHOP, Improvement of Therapy of Elderly Patients With CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine
2011-11-01
2024-05-01
Active, not recruiting
1,152
TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study
2012-08-24
2022-05-31
Completed
717
A Phase III Trial on the Effect of Elotuzumab in VRD Induction /Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma
2015-06-01
2021-06-24
Completed
564
Trial on the Effect of Isatuximab to Lenalidomide/Bortezomib/Dexamethasone (RVd) Induction and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma (GMMG HD7)
2018-10-18
2025-12-01
Active, not recruiting
662
HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT)
2020-12-17
2027-05-01
Recruiting
200
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus Barmherzige Brüder Regensburg, Klinik für Onkologie und Hämatologie"
#1 collaborator was "Deutsche Krebshilfe e.V., Bonn (Germany)" with 1 trials as a collaborator, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials as a collaborator and "Spectrum Pharmaceuticals, Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Krankenhaus Barmherzige Brüder Regensburg, Klinik für Onkologie und Hämatologie
According to Clinical.Site data, the most researched conditions in "Krankenhaus Barmherzige Brüder Regensburg, Klinik für Onkologie und Hämatologie" are
"Multiple Myeloma" (2 trials), "CD20+ Aggressive B-Cell Lymphoma" (1 trials), "Chronic Myeloid Leukemia" (1 trials), "Gastric Cancer" (1 trials) and "Gastroesophageal Junction Adenocarcinoma" (1 trials). Many other conditions were trialed in "Krankenhaus Barmherzige Brüder Regensburg, Klinik für Onkologie und Hämatologie" in a lesser frequency.
Clinical Trials Intervention Types at Krankenhaus Barmherzige Brüder Regensburg, Klinik für Onkologie und Hämatologie
Most popular intervention types in "Krankenhaus Barmherzige Brüder Regensburg, Klinik für Onkologie und Hämatologie" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Bortezomib" (2 trials), "Dexamethasone" (2 trials), "Lenalidomide" (2 trials), "5-Fluorouracil" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Krankenhaus Barmherzige Brüder Regensburg, Klinik für Onkologie und Hämatologie
The vast majority of trials in "Krankenhaus Barmherzige Brüder Regensburg, Klinik für Onkologie und Hämatologie" are
5 trials for "All" genders.
Clinical Trials Status at Krankenhaus Barmherzige Brüder Regensburg, Klinik für Onkologie und Hämatologie
Currently, there are NaN active trials in "Krankenhaus Barmherzige Brüder Regensburg, Klinik für Onkologie und Hämatologie".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Krankenhaus Barmherzige Brüder Regensburg, Klinik für Onkologie und Hämatologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Krankenhaus Barmherzige Brüder Regensburg, Klinik für Onkologie und Hämatologie, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".